By Carlo Martuscelli

GlaxoSmithKline PLC (GSK.LN) has offered unspecified concessions to address competition concerns over its proposed healthcare joint venture with Pfizer Inc. (PFE), the European Commission said Thursday.

The EU authority said it will come to a decision on the proposed combination by July 10.

The U.K. pharmaceutical company in December said it planned to create a consumer health-focused joint venture with U.S. drugmaker Pfizer, with the aim of eventually spinning it off.

The plans are being investigated by the EU's competition body to make sure that they don't breach market rules.

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com

(END) Dow Jones Newswires

June 20, 2019 06:38 ET (10:38 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Pfizer
Pfizer (NYSE:PFE)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Pfizer